BNR

Burning Rock Biotech Ltd

Nasdaq · Services-Medical Laboratories · CIK 0001792267
$8.18 -9.81% $95.7M
Vol
Market Cap$95.7M
Cap SizeMicro Cap
Inst. Holders3 funds
Inst. Value$1.5M
Inst. Activity0 buys / 1 sells
Insider Activity1B / 0S
Insider Net $$5.5M
SEC Reports2
Press Releases2
Exchange Nasdaq·Sector Services-Medical Laboratories·CIK 0001792267·Prev Close $9.07

Analyst Ratings

Historical distribution80% buy · 5 analysts · last covering-analyst action Jul 2021
1Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 14, 2021 CICC INITIATE Outperform
Jul 13, 2020 B of A Securities INITIATE Buy
Jul 7, 2020 Cowen & Co. INITIATE Outperform

Top Institutional Holders

FundValueMove
RENAISSANCE TECHNOLOGIES LLC$627.0K
BANK OF AMERICA CORP$587.9K
MORGAN STANLEY$238.6KTRIM

Recent Insider Trades

DateInsiderTypeValue
Mar 31, 2026Han YushengBUY$5.5M
3 institutional holders with $1.5M total value (72,135 shares) as of 2025-Q4. Top holders: RENAISSANCE, BANK, MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1RENAISSANCE TECHNOLOGIES LLC31,117$627.0K43.1%
2BANK OF AMERICA CORP /DE/29,178$587.9K40.4%
3MORGAN STANLEY11,840$238.6K16.4%TRIM -46.8%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYTRIM22,26711,840-46.8%$238.6K2025-Q4
MORGAN STANLEYADD10,72618,207+69.7%$57.5K2025-Q2
UBS Group AGDOUBLED110709+544.5%$2.2K2025-Q2
UBS Group AGNEAR_EXIT1,430110-92.3%$495.002025-Q1
CITADEL ADVISORS LLCEXIT12,2670-100.0%$0.002025-Q1
CITADEL ADVISORS LLCNEW12,267$82.8K2024-Q4
UBS Group AGTRIM4,2451,430-66.3%$9.7K2024-Q4
MORGAN STANLEYTRIM15,98310,426-34.8%$34.0K2024-Q3
1 unique insiders with 1 transactions. Net insider value: $5.5M ($5.5M bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Mar 31, 2026Han YushengDirectorBUY314,870$17.36$5.5M
Historical analyst distribution (last covering-analyst action Jul 2021): 80% buy across 5 analysts — 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2023-09-30
$0.00 $0.00 $0.00 $0.0B
Current FY
2023-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 14, 2021 CICC INITIATE Outperform
Jul 13, 2020 B of A Securities INITIATE Buy
Jul 7, 2020 Cowen & Co. INITIATE Outperform

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jan 1, 20241310080%
Dec 1, 20231310080%
Nov 1, 20231310080%
Oct 1, 20231310080%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 9, 2026
earnings
Burning Rock Reports First Quarter 2026 Financial Results
Burning Rock Reports First Quarter 2026 Financial Results
Jun 4, 2026
earnings_calendar
BNR Q1 2026 Earnings Scheduled — 2026-06-04
Apr 28, 2026
activist
Burning Rock Publishes 2025 Annual Report on Form 20-F
Burning Rock Publishes 2025 Annual Report on Form 20-F
Apr 2, 2026
other
Burning Rock Announces Founder’s Purchase of Its ADSs
Burning Rock Announces Founder’s Purchase of Its ADSs
Mar 23, 2026
earnings_calendar
BNR Q4 2025 Earnings After Market Close — 2026-03-23
Mar 12, 2026
earnings
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results